A few years ago, Austin Wrenn noticed something unsettling in his strawberry greenhouses at Wrenn's Farm in Zebulon, North Carolina. He was one of the first growers in the state to experience losses ...

New Iterative Block Particle Filter algorithm makes genomic surveillance faster, cheaper and more scalable, improving early ...

Abu Dhabi launches AI-powered virtual human twin project to drive early diagnosis, precision medicine and preventive ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...

A joint research team has developed an automated design technology that enables the creation of DNA origami structures that ...

We have identified the gene that, when activated, initiates the developmental programme that results in cells forming a human ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...

The discovery of all five nucleobases on Ryugu strengthens the idea that life’s molecular ingredients formed in space before ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National ...

For a child diagnosed with neuroblastoma-the most common infant cancer, occurring when early nerve cells grow out of control-the path to treatment isn't simple.

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.